- Home
- WHLRD vs MDCXW Comparison
WHLRD vs MDCXW Comparison
Compare WHLRD & MDCXW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WHLRD | MDCXW |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | Canada |
| Employees | 56 | 12 |
| Industry | Real Estate Investment Trusts | |
| Sector | Real Estate | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | WHLRD | MDCXW |
|---|---|---|
| Price | $37.98 | $0.96 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | N/A | ★ 6.0K |
| Earning Date | N/A | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | N/A | $1.12 |
| 52 Week High | N/A | $1.34 |
Technical Indicators
Market Signals| Indicator | WHLRD | MDCXW |
|---|---|---|
| Relative Strength Index (RSI) | 57.74 | 49.92 |
| Support Level | $36.90 | $0.93 |
| Resistance Level | $38.87 | $1.18 |
| Average True Range (ATR) | 1.25 | 0.07 |
| MACD | 0.26 | -0.00 |
| Stochastic Oscillator | 49.62 | 48.81 |
Price Performance
Historical ComparisonAbout WHLRD Wheeler Real Estate Investment Trust Inc.
Wheeler Real Estate Investment Trust Inc is a self-managed commercial real estate investment company. It owns, leases, and operates income-producing retail properties with a primary focus on grocery-anchored centers. The company's properties include Alex City Marketplace in Alexander City, Alabama; Bryan Station in Lexington, Kentucky; Cardinal Plaza in Henderson, North Carolina; Clover Plaza in Clover, South Carolina; Winslow Plaza in Sicklerville, New Jersey and many more.
About MDCXW Medicus Pharma Ltd. Warrant
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.